By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Memorial Sloan-Kettering Says No to Cancer Drug Zaltrap for Colorectal Cancer-Avastin Works Just As Well and the Cost is Half
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Memorial Sloan-Kettering Says No to Cancer Drug Zaltrap for Colorectal Cancer-Avastin Works Just As Well and the Cost is Half
BusinessNews

Memorial Sloan-Kettering Says No to Cancer Drug Zaltrap for Colorectal Cancer-Avastin Works Just As Well and the Cost is Half

BarbaraDuck
BarbaraDuck
Share
3 Min Read
SHARE

I think we may see more of these types of studies and the two doctors do state they have been paid consulting fees imagefrom Genentech (Roche) who makes Avastin.  Avastin has been around a long time and it is not cheap, costing patients about $5000 a month, but Zaltrap

I think we may see more of these types of studies and the two doctors do state they have been paid consulting fees imagefrom Genentech (Roche) who makes Avastin.  Avastin has been around a long time and it is not cheap, costing patients about $5000 a month, but Zaltrap costs twice that.  Cancer drugs and chemotherapy treatments are all over the map as far as cost.  For Medicare patients, the out of pocket cost would be $2200 for Zaltrap. 



AT Memorial Sloan-Kettering Cancer Center, we recently made a decision that should have been a no-brainer: we are not going to give a phenomenally expensive new cancer drug to our patients.

The reasons are simple: The drug, Zaltrap, has proved to be no better than a similar medicine we already have for advanced colorectal cancer, while its price — at $11,063 on average for a month of treatment — is more than twice as high.

Which brings us back to our decision on Zaltrap. In patients with advancing, metastatic colorectal cancer, the new drug, approved by the F.D.A. in August and jointly marketed by Sanofi and Regeneron, offers the same survival benefit as Genentech’s Avastin, which works through a similar molecular mechanism. When compared with the standard chemotherapy regimen alone, adding either medicine has been shown to prolong patient lives by a median of 1.4 months. Major clinical practice guidelines, like those from the National Comprehensive Cancer Network, agree that Zaltrap is no better than Avastin in this setting. (Full disclosure: Two of us, Dr. Bach and Dr. Saltz, have been paid consulting fees by Genentech.)

The writers are doctors at Memorial Sloan-Kettering Cancer Center. Peter B. Bach is the director of the Center for Health Policy and Outcomes, Leonard B. Saltz is chief of the gastrointestinal oncology service and chairman of the pharmacy and therapeutics committee, and Robert E. Wittes is the physician in chief.

http://www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html

 

More Read

The California Health Benefit Insurance Exchange
Delivering High Quality Healthcare: Measure, Improve, Measure Again
Can You Hear Me Now? Another Health Market that Really Works
Day One at the Association of Healthcare Journalists Conference in Boston
What Causes Inflammation? A Comprehensive Look At The Causes and Effects Of Inflammation (part 2)

TAGGED:cancerhealthcare costspharma
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

HIMSS 2012: Preview

February 21, 2012

The Need to Blame the Doctor, not the System

July 16, 2012
insurance on obamacare
BusinessFinanceHealth ReformPolicy & LawPublic Health

Sometimes, Even If You Like Your Insurance, You Can’t Keep It

November 6, 2013
improve air quality
Hospital Administration

Tips For What Hospitals Can Do To Improve Air Quality

November 3, 2020
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?